Necrotizing pneumonia caused by panton-valentine leukocidin-producing methicillin-susceptible staphylococcus aureus (MSSA);Polmonite necrotizzante causata da staphylococcus aureus meticillino sensibile produttore di leucocidina di panton-valentine (MSSA)

Infezioni in Medicina

Volumn 20, Issue 3, 2012, Pages 205-210

  Catena, Vincenzo ^a,b   Baiocchi, Marco ^b   Lentini, Paolo ^c   Badolati, Luigi ^b   Baccarin, Monica ^b   Del Monte, Daniele D ^a   Rubini, Alessandro ^d  

^a ULSS 2 Feltre   (Italy)

^b Ospedale San Bassiano   (Italy)

^c Ospedale S Bassiano   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Panton valentine leukocidin; Pneumonia; Staphylococcus aureus

Indexed keywords

C REACTIVE PROTEIN; CLINDAMYCIN; D DIMER; DAPTOMYCIN; IMMUNOGLOBULIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; OXACILLIN; PANTON VALENTINE LEUKOCIDIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TROPONIN I;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CASE REPORT; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; CRITICAL ILLNESS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FEVER; FLU LIKE SYNDROME; HIP PAIN; HUMAN; INGUINAL PAIN; LEUKOCYTE COUNT; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NECROTIZING PNEUMONIA; PNEUMONIA; POLYMERASE CHAIN REACTION; TACHYPNEA; THORAX DRAINAGE; TREATMENT DURATION; WEAKNESS;

ABSCESS; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; DRAINAGE; DRUG THERAPY, COMBINATION; EXOTOXINS; FOLLOW-UP STUDIES; HIP; HUMANS; IMMUNOCOMPETENCE; LEUKOCIDINS; MALE; METHICILLIN; MIDDLE AGED; NECROSIS; PNEUMONIA, STAPHYLOCOCCAL; RESPIRATION, ARTIFICIAL; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 84866946087     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lowi S.D. Staphylococcus aureus infections. N. Engl. J. Med. 339, 520-532, 1998.
2. Grundmann H., Aires de Sousa M., Boyce J., Tiemersma E. Emergence and resurgence of meticillinresistant Staphylococcus aureus as a public-health theatre. Lancet 368, 874-875, 2006.
3. Kaneko J., Kamio Y. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxin: structure, pore-forming mechanism, and organization of the genes. Biosci. Biotechnol. Biochem. 68, 981-1003, 2004.
4. Boyle-Varra S., Daum R.S. Community acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab. Invest. 87, 3-9, 2004.
5. Thor Levy M.M., Fink M.P., Marshall J.C., et al. SCCM/ESICM/ACCP/ATS/SIS 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 31, 1250-1256, 2003.
6. Lim W., van der Eerden M.M., Laing R., et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58, 5, 377-382, 2003.
7. Atabai K., Matthay M.A. The pulmonary physician in critical care. 5: Acute lung injury and the acute respiratory distress syndrome: definitions and epidemiology. Thorax 57, 452-458, 2002.
8. Gauduchon V., Cozon G., Vandenesch F., et al. Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J. Infect. Dis. 189, 346-353, 2004.
9. Morgan M.S. Diagnosis and treatment of Panton- Valentine leukocidin (PVL)-associated staphylococcal pneumonia. Int. J. Antimicrob. Agents 30, 289-296, 2007.
10. Tseng C.W., Kyme P., Low J., Rocha M.A., Alsabeh R. Staphylococcus aureus Panton Valentine leukocidin contributes to inflammation and muscle tissue injury. PLoS One 27, 4, e6387, 2009.
11. Varshney A., Martinez L.R., Hamilton S.M., et al. Augmented production of Panton-Valentine leukocidin toxin in methicillin-resistant and methicillinsusceptible Staphylococcus aureus is associated with worse outcome in a murine skin infection model. J. Infect Dis. 201, 1, 92-96, 2010.
12. The Center for Disease Control and Prevention. Four pediatric deaths from community-acquired Methicillin- resistant Staphylococcus aureus - Minnesota and North Dakota 1997-1999. JAMA 282,1123-1125, 1999.
13. Finelli L., Fiore A., Dhara L. et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatric 122, 805-811, 2008.
14. Kallen A.J., Brunkard J., Moore Z., et al. Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann. Emerg. Med. 53, 358-365, 2009.
15. Hageman J.C., Uyeki T.M., Francis J.S., et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg. Infect. Dis. 12, 894-899, 2006.
16. Prevost G., Couppie P., Prevost P., et al. Epidemiological data on Staphylococcus aureus strain producing synergohymenotropic toxins. J. Med. Microbiol. 42, 237-245, 1995.
17. Gillet Y., Issartel B., Vanhems P., et al. Association between Staphylococcus aureus strain carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359, 753-759, 2002.
18. Lina G., Piemont Y., Godail-Gamot F., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29, 1128-1132, 1999.
19. de Bentzmann S., Tristan A., Etienne J., Brousse N., Vandenesch F., Lina G. Staphylococcus aureus isolates associated with necrotizing pneumonia bind to basement membrane type I and IV collagens and laminin. J. Infect. Dis. 190, 1506-1515, 2004.
20. Diep B.A, Sensabaugh G.F., Somboona N.S., Carleton H.A., Perdreau-Remington F. Widespread skin and soft-tissue due to two methicillin resistant Staphylococcus aureus strain harboring the genes for Panton-Valentine leucokidine. J. Clin. Microbiol. 42, 2080-2084, 2004.
21. Soavi L., Signorini L., Stellini R., et al. Linezolid and clindamycin improve the outcome of severe, necrotizing pneumonia due to community-acquired methicillin-resistant Staphylococcus aureus. Infezioni in Medicina 1, 42-44, 2011.
22. Stevens D.L., Ma Y., Salmi D.B., McIndoo E., Wallace R.J., Bryant A.E. Impact of antibiotic on expression of virulence-associated exotoxin genes in methicillin-susceptible and methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 195, 2, 202-211, 2007.
23. Gattuso G., Palvarini L., Tomasoni D., Ferri F., Scalzini A. A case of community-acquired MRSA (CA-MRSA) sepsis complicated by meningoencephalitis and cerebral abscess, successfully treated with linezolid. Infezioni in Medicina 4, 244-248, 2009.
24. Kollef M.H. Limitation of vancomicin in the management of resistant staphylococcal infections. Clin. Infect. Dis. 45, S191-S195, 2007.
25. Kreienbuel L., Charbonney E., Eggiman P. Community- acquired necrotizing pneumonia due to methicillin- susceptible Sthaphylococcus aureus secreting Panton-Valentine leucokidin: a rewiew of case reports. Ann. Intensive Care 1, 52, 2011.
26. Liu C., Bayer A., Cosgrove S.E., et al. Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary. Clin. Infect. Dis. 52, 3, 285-292, 2011.